Letter to the Editor: Vagal Blocking (vBloc) Therapy: a New Era of Clinical Therapy for Extreme Obesity : Re: Apovian et al. Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial. Obesity Surgery. 2016
Obes Surg
.
2017 Feb;27(2):483-484.
doi: 10.1007/s11695-016-2484-6.
Authors
Shannon K Boi
1
2
,
Justin X Moore
3
4
,
Kendra J Royston
3
5
,
Wendy Demark-Wahnefried
3
6
Affiliations
1
University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. sboi@uab.edu.
2
Graduate Biomedical Sciences - Immunology Theme, University of Alabama at Birmingham, Birmingham, AL, USA. sboi@uab.edu.
3
University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
4
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
5
Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
6
Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
PMID:
27933506
PMCID:
PMC5239744
DOI:
10.1007/s11695-016-2484-6
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Bariatric Surgery
Humans
Obesity*
Obesity, Morbid*
Vagus Nerve
Grants and funding
R25 CA047888/CA/NCI NIH HHS/United States